h2o2 specific electrode (World Precision Instruments)
93
Structured Review
World Precision Instruments
h2o2 specific electrode
H2o2 Specific Electrode, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h2o2+specific+electrode/Hydrogen+Peroxide+Macro+Sensor/pm40210617-303-20-23
Average 93 stars, based on 30 article reviews
H2o2 Specific Electrode, supplied by World Precision Instruments, used in various techniques. Bioz Stars score: 93/100, based on 30 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/h2o2+specific+electrode/Hydrogen+Peroxide+Macro+Sensor/pm40210617-303-20-23
Average 93 stars, based on 30 article reviews
h2o2 specific electrode - by Bioz Stars,
2026-09
93/100 stars
Images
Related Articles
Software:Article Title: Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease. Article Snippet: .. Subsequently, 10 nM bovine LPO (Sigma-Aldrich) was added to the reaction buffer (final reaction volume was 1mL) and H2O2 consumption continuously recorded for a further 8min using an Article Title: Polyamine-Conjugated Nitroxides Are Efficacious Inhibitors of Oxidative Reactions Catalyzed by Endothelial-Localized Myeloperoxidase. Article Snippet: The heme enzyme myeloperoxidase (MPO) is a key mediator of endothelial dysfunction and a therapeutic target in cardiovascular disease.. During inflammation, MPO released by circulating leukocytes is internalized by endothelial cells and transcytosed into the subendothelial extracellular matrix of diseased vessels.. At this site, MPO mediates endothelial dysfunction by catalytically consuming nitric oxide (NO) and producing reactive oxidants, hypochlorous acid (HOCl) and the nitrogen dioxide radical (NO2). Article Title: Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents. Article Snippet: Accepted Manuscript Regulation of the Nitric Oxide Oxidase Activity of Myeloperoxidase by Pharmacological Agents Sophie L. Maiocchi, Jonathan C. Morris, Martin D. Rees, Shane R. Thomas PII: S0006-2952(17)30162-4 DOI: http://dx.doi.org/10.1016/j.bcp.2017.03.016 Reference: BCP 12770 To appear in: Biochemical Pharmacology Received Date: 22 December 2016 Accepted Date: 22 March 2017 Please cite this article as: S.L.. Maiocchi, J.C. Morris, M.D.. Rees, S.R. Generated:Article Title: Targeting vascular adhesion protein-1 and myeloperoxidase with a dual inhibitor SNT-8370 in preclinical models of inflammatory disease. Article Snippet: Briefly, LDL (0.2mg protein/mL) in 50mM sodium phosphate buffer (pH 7.4) supplemented with 100μM DTPA was incubated at 37 °C in the presence of 30 nM MPO, 0.5mM NaNO2 and 500μg/mLglucoseplus 100ng/mLglucoseoxidase (Sigma Aldrich) for 2 h in the absence or presence of test inhibitors (0–10μM) in a final reaction volume of 100μL. .. The concentrations of glucose/ glucose oxidase employed generated a constant flux of H2O2 of ~1μM/ min, as verified by an Concentration Assay:Article Title: Regulation of the nitric oxide oxidase activity of myeloperoxidase by pharmacological agents. Article Snippet: Accepted Manuscript Regulation of the Nitric Oxide Oxidase Activity of Myeloperoxidase by Pharmacological Agents Sophie L. Maiocchi, Jonathan C. Morris, Martin D. Rees, Shane R. Thomas PII: S0006-2952(17)30162-4 DOI: http://dx.doi.org/10.1016/j.bcp.2017.03.016 Reference: BCP 12770 To appear in: Biochemical Pharmacology Received Date: 22 December 2016 Accepted Date: 22 March 2017 Please cite this article as: S.L.. Maiocchi, J.C. Morris, M.D.. Rees, S.R. |